IDiyas

For the Inventor, By the Inventor

Saffron Walden, United Kingdom

Christine Edwards

USPTO Granted Patents = 15

 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Flex Meadow, GB (2013)
  • Harlow, GB (2011 - 2015)
  • Essex, GB (2012 - 2015)
  • Saffron Walden, GB (2019 - 2021)
  • Parma, IT (2021 - 2023)

Company Filing History:

goldMedal13 out of 328 
 
Chiesi Farmaceutici S.p.a.
 patents
silverMedal1 out of 5 
 
Pulmagen Therapeutics (inflammation) Limited
 patents
bronzeMedal1 out of 1,168 
 
Glaxo Group Limited
 patents

Years Active: 2011-2023

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 11725007 - Meta tyrosine derivatives as rho-kinase inhibitors (2023-08-15),
2. 11578068 - Oxadiazole derivatives as Rho-Kinase Inhibitors (2023-02-14),
3. 11332468 - Azaindole derivatives as Rho-kinase inhibitors (2022-05-17),
4. 11147812 - Tyrosine analogues derivatives as Rho-kinase inhibitors (2021-10-19),
5. 10954236 - Tyrosine amide derivatives as Rho-Kinase inhibitors (2021-03-23),
6. 10584128 - Bicyclic dihydropyrimidine-carboxamide derivatives as Rho-Kinase inhibitors (2020-03-10),
7. 10501461 - Tyrosine amide derivatives as Rho-kinase inhibitors (2019-12-10),
8. 9156844 - Pyrimidine derivatives and their use in the treatment of respiratory diseases such a COPD (2015-10-13),
9. 9120802 - Pyrimidine derivatives and their use in the treatment of respiratory diseases such as COPD (2015-09-01),
10. 9023855 - Compounds (2015-05-05),
11. 8957082 - Tetrahydropyrrolopyrimidinediones and their use in therapy (2015-02-17),
12. 8691826 - Compounds (2014-04-08),
13. 8455505 - Pyrrolopyrimidinedione and its therapeutic use (2013-06-04),
14. 8198288 - Tetrahydropyrrolopyrimidinediones and their use in therapy (2012-06-12),
15. 7902224 - Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators (2011-03-08),
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…